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1. Introduction 
Atherosclerotic occlusive (AI) disease of the abdominal aorta and iliac arteries and its 
clinical manifestation is a common therapeutic challenge encountered by vascular surgeons. 
It is one subset of peripheral arterial disease which affects 8 to 10 million people in the 
United States per year. (1)  
The aortoiliac occlusive diseases ultimately start at the terminal aorta and the origin of the 
iliac arteries. The natural history of the disease is slow progression proximally and distally 
over time to end in complete occlusion of the aorta and iliac arteries. Fig: 1 
 
Fig. 1.  
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Starrett and Stony suggest that the natural history is not always benign and report that in a 
third of their patients the aortic occlusive disease extends to show thrombosis of the renal 
arteries over a period of 5 to 10 years. (2)  
Others suggest that renal arteries remain open with no incidence of extension of the 
thrombosis proximally to involve the renal or the mesenteric vessels. (3) 
Atherosclerotic occlusive disease is segmental in nature. Stenosis may be in a short or long 
segment, calcified, ulcerated, concentric or eccentric, single or multiple, unilateral or 
bilateral and may involve the aorta and iliac arteries alone or together. Approximately 30% 
of patients with infra inguinal atherosclerotic occlusive disease will have aortoiliac occlusive 
disease if their circulation is studied carefully.  
The majority of patients with atherosclerotic aortoiliac occlusive disease have diffuse disease 
involving femoro popliteal and infrageniculate vessels. They are commonly older, more 
likely to be men, have diabetes and hypertension and have concomitant coronary and 
cerebrovascular diseases. (4) 
The aortoiliac occlusive disease can involve isolated segments of the aorta and iliac vessels 
and usually presents in a younger population, female as male, and have a higher incidence 
of smoking and hypercholesterolemia as associated risk factors. 
Focal infra renal aortic stenosis with no other arteries involved is fairly rare. (5)  
Aortoiliac atherosclerotic occlusive disease is characterized by abundant collateralization 
between abdominal, pelvic and infra inguinal arteries which make the presentation with 
critical limb ischemia a rare event. A more common presentation is of claudication of 
varying severity and levels. The two exceptions to this observation are a large thrombus 
lodged at the narrow aorta causing acute limb ischemia and blue toe syndrome where micro 
emboli target the small vessels in the toes or the heel. 
Being a part of atherosclerotic disease spectrum, aortoiliac occlusive disease has many 
common risk factors most notably smoking, dyslipidemia, hypertension, diabetes mellitus, 
male gender, advanced age and high genetic risk. 
Isolated aortoiliac occlusive disease primarily occurs in younger patients, more commonly 
in females and have a higher incidence of smoking and hypercholesterolemia as associated 
risk factors. They usually have a normal life expectancy. (7) On the other hand, patients with 
aortoiliac occlusive disease and a more diffuse multilevel pattern of the disease are 
commonly older, more likely to be male, and more frequently have diabetes and 
hypertension. They have a higher incidence of concomitant coronary, cerebrovascular, and 
visceral atherosclerosis. These patients have a significant reduction in their life expectancy 
when compared with age-matched counterparts. (6) Patients with multi segment diffuse 
disease present with rest pain, tissue loss and gangrene as opposed to isolated 
claudication.(8) An aggressive form of the disease was described in a young woman who 
was a heavy cigarette smoker where a circumscribed calcified occlusive lesion of the middle 
of the aorta was found. Despite the fact that the upper abdominal aorta is usually spared in 
the aortoiliac occlusive disease, a minority of such patient has marked involvement of this 
segment of the aorta with occlusion of the origins of the visceral and renal arteries. (9) 
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2. Presenting symptoms 
Chronic obliterative atherosclerosis of the distal aorta and iliac arteries commonly manifests 
as symptomatic arterial insufficiency of the lower extremities, producing a range of 
symptoms from mild claudication to the most severe, critical limb ischemia (CLI). 
Claudication, with its characteristic association with ambulation and relief with rest, is the 
presenting symptom in most of the cases. Severity of claudication and involvement of 
muscle groups depends on the disease localization.  
Intermittent claudication presents with symptoms involving muscles of the thigh, hip and 
buttock as well as the calf. Because calf claudication is the early manifestation for the infra-
inguinal occlusive disease the involvement of more proximal muscle groups may help in 
identifying the aortoiliac as the diseased level of the circulatory tree. (10) 
Unfortunately, sizable numbers of the patient complain of only calf claudication.  
Isolated erectile dysfunction is the sole presenting symptom in some men due to significant 
involvement of hypo gastric arteries. At the other extreme, patients with multilevel disease 
will suffer from severe rest pain with tissue loss and is usually combined with femoro-
popliteal occlusive disease.  
Aortoiliac disease can present with classic symptoms of Leriche syndrome- namely bilateral 
lower extremity claudication, impotence, atrophy of muscles and absence of femoral pulses. 
(11) The equivalent impact of impaired pelvic perfusion in women remains poorly 
understood but has recently attracted investigative attention. (12) 
3. Diagnosis 
3.1 History and physical examination 
Evaluation of aortoiliac disease commences with a good history and physical examination. 
The diagnosis of aortoiliac occlusive disease in patients with vascular risk factors with 
buttock or high thigh claudication and absent femoral pulses is usually straightforward. 
Claudication symptoms however must be distinguished from those of nerve root irritation 
due to spinal stenosis or disk herniation or arthritis. These symptoms are produced by 
standing as well as by walking and follow sciatic nerve distribution. (13)  
The variability of presenting signs and symptoms in patients with AI disease sometimes 
leads to diagnostic confusion. Although proximal claudication is most common, patients 
with AI occlusive disease in isolation or those with combined infrainguinal disease may 
present exclusively with calf claudication. 
Acute embolism of the distal extremities and toes could be associated with chronic aortoiliac 
disease. Rare patients who present with complete acute occlusion of aorta can have 
symptoms related to intestinal and renal ischemia. 
The history will often help in determining the need of any systemic evaluation required 
including cardiac evaluation.  
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Physical examination will often reveal an absent or diminished femoral pulse. In a minority 
of patients, pulses could be palpable but will disappear with ambulatory efforts. An 
occasional bruit over the lower abdomen or groin can help in unmasking an underlying 
arterial lesion resulting in a turbulent blood flow. Advanced long-standing aortoiliac disease 
often has signs of atrophic changes such as cool, shiny, hairless skin with rubor. Patients 
with chronic multilevel disease can have atrophic leg muscles or in more severe cases 
gangrene or nonhealing ulcers. (14) 
 
 
 
Fig. 2.  
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3.2 Non invasive arterial studies 
Noninvasive laboratory testing serves two major purposes in evaluation of suspected 
aortoiliac occlusive disease: confirmation of disease when history and physical examination is 
equivocal; second to establish a baseline for follow up and assessing the therapeutic outcomes.  
Ankle-brachial indexes (ABIs), segmental pressure measurement, and pulse volume 
recordings are the three most common employed modalities. Fig. 2 
Noninvasive arterial studies show inflow problems and decrease in the thigh brachial index 
and decrease in the wave amplitude. A difference of at least 20 mm Hg between the brachial 
pressure and the proximal thigh pressure reflects a significant stenosis in the aorta or iliac 
arteries, but it may be confused by proximal SFA occlusion. A further reduction in pressure 
between the thigh and ankle level is consistent with concomitant SFA, popliteal, or tibial 
outflow disease. (15) 
Patients with disabling claudication occasionally demonstrate normal or near normal ankle 
brachial indices. Repeating the tests after a period of gradual exercise show marked fall in 
the ankle brachial index if the patients have significant aortoiliac disease. (16) 
Noninvasive evaluation is sufficient for diagnosis of aortoiliac occlusive disease in most of the 
patients. If patient is deemed suitable for operative intervention, further disease localization is 
determined with Duplex sonography and CT angiography (CTA) or MR angiography (MRA). 
4. Imaging 
4.1 Duplex ultrasound 
By an experienced technician, duplex ultrasound is an excellent noninvasive tool to 
delineate arterial lesion with further color mapping and stenosis identification. Fig 3 
Duplex ultrasound is particularly useful in patients with renal insufficiency in whom 
avoidance of usage of contrast agents is important. Some institutions obtained useful 
information for preoperative planning. (17).  
Duplex assessment of the AI, renal, and visceral arteries is operator dependent, time 
consuming and needs a dedicated vascular laboratory and trained personnel. The presence 
of bowel gas, obesity and vessel tortuosity make the precise determination location and the 
severity of the stenosis difficult. We do not usually use arterial duplex as a sole modality in 
the management of aortoiliac disease. With the continuous advance in the technology, as 
operator skill and training improve, and as novel adjunctive duplex imaging agents evolve, 
this modality will likely play an increasing role in the management of patients with visceral 
and AI disease. At present, however, it remains inferior to other imaging techniques for 
preoperative planning. (18) 
5. Computerized Tomographic Angiography (CTA)  
With the development of the 64-slice multidetector scanner, with shorter acquisition time, 
high quality, non invasive and three dimensional processing capabilities CTA has become 
most frequently used imaging modality. The studies are obtained quickly, requiring no 
more than a few minutes to scan from the proximal abdominal aorta to the feet, which 
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Fig. 3.  
minimizes issues related to patient noncompliance. The three-dimensional reconstruction of 
images provides the physician not only with views of angiographic quality but also with the 
ability to rotate images along vertical and horizontal axes to obtain a 360-degree assessment 
of the vessels. A recent meta-analysis of multidetector CTA for the evaluation of the lower 
extremity arterial tree confirmed the value of this modality. This analysis revealed that CTA 
has an overall sensitivity and specificity of 96% and 97%, respectively. (19)  
Despite these excellent results, there are limitations to the widespread use of CTA. There is 
concern because of the requirement for an intravenous bolus of iodinated contrast. This high 
contrast load limits the use of CTA to patients with normal renal function, unless medical 
necessity dictates otherwise. Also, in the presence of significant amounts of arterial wall 
calcium, small arteries that are occluded with calcified plaque may be misconstrued as 
patent. The cross-sectional images must be carefully reviewed and compared with the 
reconstructed three-dimensional images. Metal artifact may obscure images in patients with 
metal implants or surgical clips in their legs. (20) 
In many centers CT angiography with three dimensional processing capabilities has 
supplanted contrast angiography and MRA as the initial imaging study of choice for 
aortoiliac occlusive disease especially for patients who are not candidates for MRA because 
of the presence of a pacemaker or other metallic implant not suitable for the magnetic field, 
and those who are unable to lie in the supine position for long periods. (21) Fig 4 
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Fig. 4.  
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6. Magnetic Resonance Angiography (MRA)  
MRA is used for the evaluation of patients with aortoiliac occlusive disease because it can 
visualize the entire arterial tree, including pedal vessels, without the use of arterial puncture 
or standard ionic contrast agents. MRA can reveal a patent pedal vessel suitable for grafting 
that was not seen on conventional angiography. Exaggeration of the degree of stenosis 
within a vessel has been noted. Contrast-enhanced MRI had a sensitivity of 92 % and a 
specificity of 92%. (22) 
MRA also has patient-related difficulties. Patients with newly placed metallic implants are 
frequently not candidates. Others may require sedation because of claustrophobia or 
difficulty lying flat for a long time. Additionally, although gadolinium is only mildly 
nephrotoxic, it may adversely affect renal function in patients with preexisting renal 
insufficiency. (23) More recently, there have been reports of nephrogenic systemic fibrosis 
related to the administration of gadolinium to patients with a glomerular filtration rate less 
than 30 mL/min. The incidence may be highest in those with end-stage renal failure who 
require hemodialysis. Although this complication is infrequent overall, in view of the large 
number of gadolinium-enhanced magnetic resonance angiograms performed each year, 
nephrogenic systemic fibrosis is associated with significant disability and mortality. (24) Fig 1 
7. Arteriography 
Digital subtraction angiography (DSA) which is the gold standard for diagnosis of all 
arterial occlusive diseases, especially if anatomic questions remain, has largely been 
replaced by computerized tomographic angiography (CTA) and MRA and increasingly been 
selectively performed for endovascular intervention. Fig 5 
In many centers magnetic resonance angiography with three dimensional processing 
capabilities has supplanted contrast angiography as the initial imaging study of choice. 
When CTA or MRA show a lesion which is amenable for percutaneous intervention 
arteriography is then performed for confirming the finding and for treatment. If the 
anatomic pattern is unfavorable to a percutaneous approach, aortoiliac reconstruction can be 
planned directly from the information obtained by MRA or CTA. In cases in which the 
decision has been made to proceed with surgical revascularization, angiography may be 
undertaken to obtain a final detailed roadmap of the relevant anatomy. (25) Attention 
should be directed to the inferior mesenteric artery; a large patent inferior mesenteric artery, 
particularly in the presence of superior mesenteric artery or hypogastric artery occlusive 
disease, may require preservation during aortic reconstruction to avoid potentially 
disastrous bowel ischemia. Multiple projections of the iliac and femoral bifurcations are 
essential to clarify the extent of disease in these regions. Full runoff views of the lower 
extremities are also needed to assess the presence or absence of femoropopliteal or tibial 
disease. (26) 
Standard retrograde femoral approach is used more frequently despite long-segment near-
occlusive or occlusive aortic or bi-iliac disease. Lateral and oblique views of the abdominal 
aorta are essential to delineate possible concomitant mesenteric or renal artery occlusive 
disease. Transbrachial approach is sometimes required. (27) 
www.intechopen.com
 
Aortoiliac Occlusive Disease 
 
11 
 
Fig. 5.  
At the time of angiogram, obtaining pressure gradient across the iliac artery lesions of 
doubtful significance is a useful technique to demonstrate whether such lesions are 
interfering with the blood flow. Measurements should be obtained and if there is no 
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significant difference, it should be repeated after induction of vasodilatation in the arteries 
of the lower extremities by intra-arterial injection of papaverine. Alternatively, causing 
reactive hyperemia by applying a tourniquet to the lower extremity. A resting systolic  
 
A 
 
B 
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Fig. 6.  
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gradient of approximately 5 to 10 mm Hg or a change in the systolic pressure greater than 
15% following pharmacologic vasodilatation is a reliable indicator of disease warranting 
inflow revascularization. (28) Because there is no image loss induced by arterial wall 
calcium, angiography is required in patients in whom the distal vasculature cannot be 
completely evaluated. Angiography is associated with higher morbidity and mortality risks, 
however, than other imaging modalities. There is an estimated 0.1% risk of a significant 
reaction to the contrast medium, a 0.16% risk of mortality, and a 0.7% risk of a serious 
complication adversely affecting planned therapy. (29) Fig 6 (A-D) 
Patients with borderline renal function, especially those who are diabetic, present a special 
challenge. Improvements in image processing have renewed the interest in carbon dioxide 
angiography, a modality that can clearly delineate both large, high-flow vessels and smaller, 
distal vessels. The gas infusion is well tolerated and has no adverse effect on renal function, 
although it may be difficult to clear in patients with severe chronic obstructive pulmonary 
disease. (30) In patient with renal insufficiency angiography using carbon dioxide as a 
contrast has been used routinely in our institute. 
Whatever the modality used for the diagnosis of aorto iliac occlusive disease, delineation of 
the infrainguinal arterial tree is essential in the pre intervention planning. Fig 7 
Adoption of these advanced diagnostic modalities has made the diagnosis of aortoiliac 
disease very straightforward. Nonetheless, there will always be patients presenting with 
lower extremity pain when other causes are responsible for the symptoms. Most often 
neurogenic claudication, arthritis of hip joints and peripheral nerve disease are the culprits. 
Again a good history and physical examination supplemented with noninvasive evaluations 
should be sufficient to distinguish these diagnoses. Determination of the contribution of 
these associated causes in symptomatology prior to any therapeutic intervention will help in 
avoiding disappointment with the outcome. 
8. Treatment of aortoiliac occlusive disease 
Management of aortoiliac occlusive disease present a unique challenge due to the complex 
interplay of factors that must be considered, including the underlying pathology, 
anatomic defect, presence of distal disease, degree of ischemia, co-morbid conditions, 
functional status, ambulation potential, and suitability of anatomy for successful 
revascularization.  
In general patients with lower extremity ischemia are typically divided into two groups in 
regard to their presentation, those with intermittent claudication and those with critical limb 
ischemia (CLI). (31)  
There is an agreement on the treatment of the CLI because the natural history of untreated 
CLI more frequently leads to limb loss. Patients with CLI often have severe associated 
cardiovascular co-morbidities and are generally older and in poorer health than those with 
claudication. In contrast, patients with claudication typically seek treatment for the relief of 
lifestyle-limiting pain with ambulation. These patients exhibit a more benign natural history 
with respect to limb viability, with amputation rates of 1% to 7% at 5 years and clinical 
deterioration of the limb in only 25%.(32) 
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Fig. 7.  
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9. Medical therapy 
In patient with CLI, claudication is a marker of significant systemic atherosclerosis, with 
associated cardiovascular mortality rates at 1, 5, and 10 years as high as 12%, 42%, and 65%, 
respectively. All patients with PAD require medical management and often benefit from 
interventional or surgical treatment, as discussed later.(30) 
Medical therapy plays an essential part in the management regimen of aortoiliac occlusive 
disease. It is instituted in all patients with the aims of symptom improvement, prevention of 
limb loss and reduction of the risk of cardiovascular complications. Risk factor modification 
is an integral part of medical therapy. Smoking cessation and an optimal control of diabetes 
mellitus, hypertension and hyperlipidemia has been shown to reduce the proliferation of the 
atherosclerotic disease process. (32) The primary care physician in collaboration with the 
vascular surgeon should follow the risk-factor modification guidelines.  
 
Parameter Target Goal Therapy 
Blood pressure Systolic <130 to 140 mm Hg 
 
Diastolic <80 to 90 mm Hg 
β-Blockers, ACE inhibitors 
Diabetes 
mellitus 
Hemoglobin A1c <7% Insulin, ↑ insulin sensitivity 
LDL cholesterol <100 mg/dL Diet, statins 
HDL cholesterol Men, ≥35 mg/dL 
 
Women, ≥45 mg/dL 
Diet, fibric acid derivative 
Tobacco 
cessation 
Complete abstinence Nicotine replacement, 
antidepressants, behavioral 
therapy 
Exercise therapy All patients Supervised program three or 
more times a week 
Antiplatelet 
therapy 
All patients Aspirin (81 or 325 mg/day), 
clopidogrel (75 mg/day) 
Pharmacologic 
therapy 
Trial in all patients with claudication 
in the absence of heart failure 
Cilostazol 
Hirsch AT, Haskal ZJ, Hertzer NR, et al: ACC/AHA guidelines for the management of patients with 
peripheral arterial disease: summary of recommendations,J Vasc Interv Radiol 17(9):1383–1397, 2006. 
ACE, Angiotensin-converting enzyme; LDL, low-density lipoprotein; HDL, high-density lipoprotein. 
Table 1. American College of Cardiology/American Heart Association guidelines for the 
management of patients with peripheral arterial disease 
Smoking cessation has been shown to reduce the risk of MI and death in patients with PAD 
and to delay the progression of lower extremity symptoms from claudication to CLI and 
limb loss.(34) The importance of smoking cessation extends to patients who have undergone 
lower extremity revascularization because there is a threefold increased risk of graft failure 
in smokers compared with nonsmokers. (35) 
In association with the risk-factor modification, daily exercise regimen can also significantly 
alleviate the symptoms and help in regaining some functional capacity. An increased 
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tolerance to demand ischemia has been postulated as a probable mechanism for such 
observed improvement. 
Institution of antiplatelet therapy is often prudent in aortoiliac occlusive disease. Although 
antiplatelet agents have not been shown to directly improve the outcome of aortoiliac 
occlusive or peripheral arterial disease, aspirin or clopidigrel do achieve a significant 
improvement in the treatment of atherosclerotic disease of coronary and cerebral arterial 
systems. Cilostazol (100 mg two times a day) is effective in increasing overall ambulation 
distance. This medication is limited to patients with peripheral arterial disease with 
intermittent claudication and no history of congestive heart failure. 
Other pharmacological agents like pentoxifylline can also be used but none of these agents 
have been shown to gain a significant practical improvement in symptoms.(33) 
In claudication there is a convincing data suggesting that the efficacy of medical treatment is 
comparable to interventional therapy like Edinburgh walking study. 
In Critical limb ischemia medical treatment plays a secondary role and revascularization is 
the essential component for limb salvage. 
10. Surgical and endovascular treatment 
The indications for surgery and intervention in symptomatic aortoiliac disease are disabling 
claudication and ischemia at rest manifested by rest pain in the foot, ischemic ulceration or 
pre gangrenous skin changes. (1) 
10.1 Open vs. endovascular 
Traditionally aortoiliac occlusive lesions were operated by an open approach. 
Aortobifemoral bypass is the method of choice. Increasingly endovascular techniques are 
being adopted for less severe occlusion when there is no extensive involvement of aorta or 
common iliac arteries. Also for patients with severe comorbidities endovascular methods 
could be an alternative. 
A significant change has occurred in the treatment of atherosclerotic arterial disease. 
Angioplasty and stenting have become first-line therapy for most patients with aortoiliac 
occlusive disease. An 850% increase in the use of percutaneous transluminal angioplasty 
and stenting for AI occlusive disease from 1996 to 2000, along with a simultaneous decrease 
of 16% in the rate of aortobifemoral grafting. (36) 
The Trans-Atlantic Inter-Society Consensus for the Management of Peripheral Arterial 
Disease (TASC) published a document authored by a working group of representatives 
from 14 surgical vascular, cardiovascular, and radiologic societies and upgraded document 
(TASC II) was published in January 2007. These important works interpreted evidence-
based data concerning the treatment of lower extremity PAD and offered a series of 
treatment recommendations based on presentation. (1) Fig 8 
Whereas percutaneous treatment of the aorta and iliac arteries was previously limited to 
short-segment, Trans-Atlantic Inter-Society Consensus (TASC) type A or B iliac lesions, 
wire-based technology has now been successfully applied to even long-segment (TASC type 
D) occlusions extending for the length of the iliac arteries. (36). 
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Fig. 8. TASC classification of aortoiliac lesions. AAA, abdominal aortic aneurysm; CFA, 
common femoral artery; CIA, common iliac artery; EIA, external iliac artery.  
Surgical risk assessment is routinely performed preoperatively as coronary artery disease 
and other comorbidities have frequently been shown to be associated with aortoiliac 
occlusive disease. 
11. Open procedures 
Open surgery for aortoiliac disease become a second- or even third-line therapy and is 
increasingly undertaken in patients in whom endovascular treatment has been technically 
unsuccessful or in those with such extensive disease that an endovascular approach is 
deemed inadvisable. Patients with a combination of more proximal aneurysmal disease and 
common or external iliac occlusive disease continue to be good candidates for open 
reconstruction. (37) Patients with disease extending to the CFA are can potentially be 
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managed with a hybrid approach, whereby the CFA plaque is treated with a traditional 
endarterectomy and patch repair and the iliac component is concurrently addressed with 
endovascular techniques. (38) Patients with significant renal failure in whom endovascular 
therapy entails a prohibitive risk of triggering dialysis dependence are also considered 
better suited for operative repair.  
Preoperative evaluation of the patients with aortoiliac occlusive disease and assessment of 
the factors that can increase the intra operative and postoperative complication are essential. 
About 50% of patients with aortoiliac occlusive disease have evidence of coronary artery 
disease. Despite the fact that myocardial infarction remains the leading perioperative 
complication, the reduced perioperative mortality and morbidity after aorto iliac surgery are 
due to advance in the treatment of concomitant coronary artery diseases. The routine use of 
perioperative beta blockade is probably the most important practice. The cardioprotective 
value of continuing aspirin through the time of AI reconstruction has now been clearly 
documented. Patient with mild or stable coronary artery disease with no recent angina or 
myocardial infarction can go for surgery without great risk. Patient with unstable angina or 
recent MI will need more investigation and coronary revascularization first. (39) 
Patients with renal insufficiency should be given time for their kidneys to recover from the 
effect of the contrast and also be hydrated. Pulmonary function should be optimized in 
patients with restrictive pulmonary disease with bronchodilators and smoking cessation 
before going for aortoiliac surgery.  
Preoperative fluid status optimization, adequate intravenous access, intra-arterial pressure 
monitoring, Foley catheter placement, and preoperative antibiotics to minimize the risk of 
prosthetic and wound infection are routine aspects of aortic replacement surgery. (40) 
Attention should be paid to maintaining normothermia throughout the procedure to reduce 
the significant organ dysfunction and operative mortality associated with intraoperative 
hypothermia. An epidural catheter is usually placed for postoperative pain control. (41) 
11.1 Aortofemoral bypass graft 
As mentioned earlier, aortofemoral bypass graft isthe most preferred surgical method 
whenever feasible.  
In the standard operative technique the femoral vessels are typically exposed first to reduce 
the time during which the abdomen is open and the viscera exposed. The extent of exposure 
is dictated by the severity of disease and the level of reconstruction planned at the CFA and 
its bifurcation. A crossing vein normally present beneath the inguinal ligament must be 
ligated or carefully avoided to prevent bleeding during the tunneling process. 
Infrarenal aortic exposure is often performed through a transperitoneal approach via a 
longitudinal midline laparotomy; some surgeons prefer a transverse incision. The abdomen 
is explored for any other pathology. The transverse colon is retracted cephalad, and the 
small bowel is shifted to the patient's right side. The duodenum is mobilized to the right, 
allowing access to the infrarenal aorta. The retroperitoneal tissue overlying the aorta is 
dissected superiorly to the level of the left renal vein, and the larger lymphatic vessels 
encountered within the retroperitoneal lymphatic network are ligated. Careful dissection 
should be used below the left renal artery to avoid injury to the lumber vein draining to the 
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left renal and to gonadal vein. Extensive dissection anterior to the aortic bifurcation and 
proximal left iliac artery should be avoided because the autonomic nerve plexus regulating 
erection and ejaculation in men sweeps over the aorta in this region.  
It is important to extend the reconstruction close to the level of the renal arteries to minimize 
the risk of failure secondary to disease progression. If end-to-side repair is planned, 
exposing and controlling all relevant lumbar or accessory renal arteries before performing 
the aortotomy helps avoid backbleeding. 
Creation of the tunnel for the graft is done by finger dissection on the anterior surface of the 
iliac arteries. On the left side, the tunnel passes beneath the sigmoid mesentery and slightly 
more laterally in an effort to avoid disruption of the autonomic nerve plexus. Moist 
umbilical tapes or Penrose drains are passed with a smooth aortic clamp to mark the 
tunnels. With vessel exposure and tunnel creation complete, but before vascular occlusion, 
heparin for anticoagulation is given as an intravenous bolus and repeated doses may be 
necessary, depending on the length of the clamp placement. 
The aorta is clamped first proximally at the site of least disease to avoid dislodgement and 
potential distal embolization of plaque. If an end-to-end anastomosis is planned, the aorta is 
transected below the proximal clamp, and the distal aorta is oversewn in two layers with 
running monofilament suture. 
Although some surgeons prefer polytetrafluoroethylene (PTFE) grafts, knitted polyester 
(Dacron) grafts are more commonly used. 
There is still considerable debate involves the type of proximal anastomosis, both end-to-
end and end-to-side techniques are acceptable and effective and each may be preferred in 
certain circumstances. 
Surgeons favoring an end-to-end anastomosis claim that it has less turbulence, lower rates 
of proximal suture line pseudoaneurysm and better long-term patency rates reported in 
some series. (42) The graft lies flatter in the retroperitoneum, this enhances the ability to 
close the retroperitoneum over the graft, resulting in a lower rate of late graft infection and 
aortoenteric fistulae. 
There are certain circumstances when an end-to-side proximal anastomosis is advantageous. 
The most common indication is in patients with occluded or severely diseased external iliac 
arteries but patent common and internal iliac arteries. Without the retrograde flow through 
the external iliac arteries normally present in an end-to-end configuration, pelvic ischemia, 
ranging from mild hip claudication to severe buttock rest pain or ulceration, may result. (43) 
Additional ischemic complications, such as erectile dysfunction in males and rarely seen 
paraplegia. (44) 
Large inferior mesenteric artery with little back flow and important accessory renal artery 
can be re-implanted to the graft.  
The graft limbs are then passed through the retroperitoneal tunnels, taking care to prevent 
twisting and to eliminate excess redundancy. Care is taken to match graft size to femoral 
artery diameter. Arteriotomy limited to the distal CFA sometimes is sufficient. More 
commonly, extension of the arteriotomy across the profunda femoris artery origin and 
profundaplasty will prove necessary. The distal anastomoses are completed in an end-to-
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side fashion using flushing maneuvers before completing the anastomoses. It is very 
important to alert the anesthetic team before releaseing the clamp, to be prepared to avoid 
blood pressure drop with reperfusion. 
Once hemostasis is sufficient, the abdomen is irrigated and the retroperitoneum is closed. If 
adequate retroperitoneal coverage is not possible, particularly with an end-to-side proximal 
anastomosis, a sleeve of omentum should be fashioned to cover any exposed segment of the 
anastomosis and to separate the graft from the adjacent bowel. The groin wounds are 
copiously irrigated with antibiotic solution, and the deeper tissue is closed in several layers 
using absorbable Vicryl sutures. 
Confirm adequate distal perfusion and ensure that no distal embolization has occurred. 
Although aortobifemoral bypass is easier and has better long term patency compared to 
aortobiiliac bypass, in certain circumstances performing an aortobiiliac bypass remains 
advantageous. In patients with hostile groin creases from prior surgery or radiation therapy, 
or are obese, diabetic patients with an intertriginous rash at the inguinal crease and patent 
external iliac arteries, the impact of synchronous SFA disease on the results of AI 
revascularization remains undefined. Although up to 80% of patients with claudication and 
both inflow and outflow disease manifest symptomatic improvement following 
aortofemoral bypass grafting alone. (45) If significant tissue loss is present, concurrent 
inflow and outflow procedures are likely warranted if limb salvage is to be achieved. (46)  
The graft patency rates continues to improve and the accumulated experience to date has 
shown that 5-year primary patency rates between 85% and 90% and 10-year rates between 
75% and 85% can be expected with aortobifemoral grafting 
Similarly the perioperative mortality rate continues to decline and less than 2% mortality is 
a standard now. (47, 48) Age has proved to be a significant predictor of outcome; in one 
report, primary patency rates at 5 years were greater than 95% for patients older than 60 
years but only 66% for those younger than 50 years. (49) 
11.2 Complications 
Reported overall morbidity rates range from 17% to 32% following aortic surgery for 
occlusive disease include cardiac complications which are the most common cause of 
mortality and result from the hemodynamic stress associated with major vascular surgery 
and the obligatory fluid shifts during the early postoperative period. Pulmonary 
complications are most likely to occur in the elderly or those with chronic obstructive 
pulmonary disease. Acute renal failure following aortic reconstruction for occlusive disease 
is relatively uncommon in patients with normal preoperative renal function. 
Adequate hydration and avoiding repetitive aortic cross-clamping and perioperative 
hypotension are valuable prophylactic maneuvers; the adjunctive use of mannitol and 
furosemide (Lasix) prior to aortic cross-clamping is less documented despite its wide use. 
Intraoperative injury to the ureters during dissection, graft tunneling, intraoperative injury 
to the small and large bowel can usually be avoided with careful surgical technique. For 
patients undergoing aortobifemoral grafting, postoperative hemorrhage is a relatively rare 
event, occurring in 1% to 2% of cases. (37, 47) 
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Careful postoperative monitoring of the abdominal girth, hematocrit, bladder pressure, 
coagulation parameters, and hemodynamic status is paramount to identify ongoing 
bleeding significant enough to require urgent reoperation. 
Intestinal ischemia following aortic reconstruction has been reported in 2% of cases. 
If compromised bowel perfusion is recognized intraoperatively inferior mesenteric artery re-
implantation is indicated. Maintaining a high index of suspicion and having a low threshold 
for performing sigmoidoscopy during the early postoperative period are critical (50) 
Spinal cord ischemia is a devastating complication of aortic surgery and the main component of 
prophylaxis is careful preservation of hypogastric perfusion. Fortunately, this complication is 
uncommon, occurring in only 0.3% of AI reconstructions for occlusive disease in one series. (51) 
Late complications following aortobifemoral grafting include graft limb thrombosis, graft 
infection, aortoenteric fistula, and anastomotic pseudoaneurysm  
Graft thrombosis is the most frequently encountered late complication. It occurs in as many 
as 30% of cases in some series in which the grafts were observed for 10 years or longer. (52) 
Inflow can frequently be restored with aggressive efforts using special thrombectomy 
catheters. If successfully restored, revising the distal anastomotic site with a profundaplasty 
or extension of the graft may prove necessary. If restoring the flow through the graft is 
unsuccessful a femorofemoral or axillofemoral graft usually suffices as a secondary source 
of inflow. 
Prosthetic graft infection is a particularly feared complication of aortic reconstruction, given 
its high associated morbidity and mortality. Diagnosis can be established with CT if there is 
clinical suspicion. Once infection is diagnosed, graft excision is usually indicated and inflow 
established with extra anatomical bypass. (53) 
Aortoenteric fistula is another rare but potentially devastating late complication associated 
with aortobifemoral. The most common pathophysiologic process is erosion of the proximal 
aortic suture line through the third or fourth portion of the duodenum, although fistulae 
between the iliac anastomoses into the small bowel or colon are also well described. 
Commonly presented with a small, self-limited bleed then become large or massive 
bleeding. Treatment is usually similar to that for graft infection; extra-anatomic bypass and 
graft removal are usually required, covering the aortic stump with adequate tissue coverage 
and repair of the involved gastrointestinal tract. (54) 
Pseudoaneurysm of the anastomotic line are far less but they continue to be seen as a late 
complication in 1% to 5% of patient after aortobifemoral bypass. They arise secondary to a 
weakening in the suture line as a result of structural fatigue or fabric degeneration. Undue 
tension, poor suturing technique, and focal weakening of the recipient arterial wall have 
been implicated as causative factors. Infection undoubtedly plays a role in many cases, 
despite the frequent absence of any obvious clinical signs; Staphylococcus species are the 
predominant organisms identified in culture. Femoral anastomotic false aneurysms are most 
common and typically present as a slowly enlarging, asymptomatic groin bulge. Given the 
potential complications of thrombosis, embolization, or rupture, repair is generally 
recommended for femoral false aneurysms larger than 2 cm or aortic false aneurysms 
greater than 50% of the graft diameter. Proximal anastomotic false aneurysms are often 
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discovered incidentally or noted when they rupture. Treatment usually consists of 
débridement of the degenerated tissue and placement of a short interposition graft. (55) 
11.3 Aortoiliac endarterectomy 
During the 1950s and 1960s, endarterectomy was the standard therapy for severe AI occlusive 
disease. Enthusiasm for the procedure dimmed, however, with the introduction of prosthetic 
graft. An obvious benefit of endarterectomy is the elimination of the need for a prosthetic 
graft, making it an appealing alternative in the setting of infection. Advocates have likewise 
pointed to the advantages of endarterectomy for younger patients or those with small vessels 
who are less than ideal candidates for endovascular therapy or aortobifemoral grafting.  
In patients with localized aortoiliac disease, aortoiliac endarterectomy may be suitable 
options and have excellent long-term patency rates, compare with aortic bypass grafting, 
have been reported. (56) In contrast, results in cases of long-segment disease involving the 
entire infrarenal aorta and extending into the external iliac arteries have been disappointing. 
(57) In our practice, aortiliac endarterectomy is rarely done. The increasing popularity of 
endovascular therapy is further decrease the small proportion of patients considered 
suitable for this reconstructive approach.  
11.4 Crossover bypass 
A few patients with only one iliac artery involvement with good aortic and contralateral 
iliac artery can be offered the choice of supra pubic ilioiliac and femorofemoral bypass graft. 
Hemodynamic studies confirm that one iliac artery can support both legs, at least at rest, in 
the absence of flow-limiting lesions in the planned donor iliac arterial system. (58, 59) Even a 
diseased donor iliac arterial system may be improved with endovascular techniques to 
allow a less invasive yet effective femorofemoral bypass when a more invasive procedure 
would otherwise be required. The majority of the studies published have found that 
iliofemoral bypass yields somewhat better patency than femorofemoral bypass, assuming 
the presence of an appropriate common iliac artery for inflow to the graft. (60-62) Ipsilateral 
iliofemoral bypass is a good procedure when anatomically feasible. Kretschmer and 
colleagues found no difference between femorofemoral bypass and unilateral iliofemoral 
bypass with respect to patency. (63) Van der Vliet and associates, in a truly remarkable 
study, compared the results of 184 unilateral iliac reconstructions (62% based on iliac artery 
inflow) to 350 contemporaneous patients undergoing aorta–to–bilateral iliac or femoral 
reconstruction over a 10-year period and found no difference in patency between the 
groups, implying that iliofemoral bypass yields results comparable to the “benchmark” 
aortofemoral bypass. (64) The abdomen is prepped along with the groins and anterior thighs 
to allow access to the abdomen in case of unexpected findings during surgery. Longitudinal 
incisions and less frequent oblique incisions are generally used to expose and control the 
femoral arteries on both sides. The graft is tunneled from one groin incision to the other 
within the abdominal wall superior to the pubis. The tunnel is created bluntly with fingers, 
a large clamp, or a tubular tunneler. The graft tunneled in the prefascial subcutaneous plane 
or in the preperitoneal position if unfavorable conditions exist in the abdominal wall, such 
as prior surgery, radiation-damaged skin or other skin changes, an unusually thin 
subcutaneous fat layer, or obesity. (65) If the inflow provided in by a contralateral iliac artery, 
these iliac origin crossover grafts are usually most conveniently placed in the preperitoneal 
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position. (66) Anastomoses are end-to-side anastomoses in nearly all cases. Kinking of the graft 
should be avoid by taking the graft lower on the common femoral to the origin of the 
profunda parallel to the artery. A prosthetic graft is now used in nearly all cases. 
Exposure for the iliac site of the anastomosis usually done through suprainguinal curved 
incision which is simple also in the obese patient avoid the groin and the graft is more 
deepley placed and more cushioned than in the femoro femoral bypass. 
It is not surprising that endovascular procedures to improve suboptimal donor iliac arteries 
might be considered prior to or concomitant with femorofemoral bypass. the results of these 
studies generally support the view that donor iliac artery balloon angioplasty with stenting in 
selected cases is associated with a satisfactory hemodynamic outcome and patency rate. (67) 
The perioperative mortality associated with femorofemoral bypass is highly dependent on 
patient selection but should be well under 5% in elective operations. Estimated 3-year 
survival rates of 71% for patients undergoing femorofemoral bypass, versus 35% for those 
having axillofemoral bypass. (67, 68) The primary and secondary patency rates for 
femorofemoral bypass at 3 to 5 years should be about 60% and 70%, respectively. (67, 69) 
There is a trend toward better patency in claudicants, consistent with observations in 
virtually every other arterial intervention. (70) 
11.5 Axillofemoral bypass 
In high risk patient with a combination of aortic and proximal iliac occlusive disease, those 
with other co-morbidities such as multiple prior abdominal operations, abdominal stomas, 
or prior radiation therapy, axillofemoral bypass is a valuable alternative for distal 
revascularization. Axillofemoral bypass is an essential tool for the treatment of many 
patients with infected aortic or prosthetic arterial grafts or aortoenteric fistulae (53,54) 
Axillofemoral bypass is nearly always performed with general anesthesia. Supine position. 
Either axillary artery can be chosen as a donor unless there is disease in the subclavian or 
axillary artery. The axillary artery on the side with the higher blood pressure is chosen if 
there is a 10 mm Hg or greater systolic pressure discrepancy between the arms. (71) A 
transverse infraclavicular incision is carried through the clavipectoral fascia, exposing the 
pectoralis major muscle. The pectoralis major muscle fibers are pushed superiorly and 
inferiorly, exposing the deep fascia and, beneath that, the fat containing the axillary vein, 
artery, and brachial plexus elements. The axillary artery is exposed from the clavicle 
medially to the pectoralis minor muscle laterally, often requiring the ligation of crossing 
veins or small arterial branches. Conventional longitudinal or oblique groin incisions are 
used for femoral artery exposure. It is very important to place the axillary graft anastomosis 
as medially as possible to avoid tension on the axillary anastomosis when the arm is 
abducted. (72) The axillofemoral graft must be tunneled in the midaxillary line to prevent 
kinking of the graft. The anastomosis of the proximal end of the graft to the side of the 
axillary artery is generally performed first. The distal anastomosis is conventionally 
performed end to side to an appropriate artery in the groin. It is important to ensure 
adequate outflow. (72) It is very important to confirm distal flow using continuous-wave 
Doppler after the anastomoses are completed and all clamps are removed. It is also essential 
to ensure adequate blood flow in the donor arm beyond the axillary anastomosis. Patency 
rates with axillofemoral bypass varies widely between 30% to as high as 85%. (73) The 
reasons for this variability is due to in part to patient selection, indication and status of the 
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outflow arteries. Patient with claudication do better than limb salvage patients because of 
the inherent outflow restriction in the latter group. Patients with a previous distal bypass 
have better results. 25% of declotted grafts go on to long term patency. (74) Due to co 
morbidities estimated survival of only 43% at 28 months after axillofemoral bypass. (75) 
Devolfe and coworkers observed an approximately 35% 3-year survival. (76) Patients whose 
initial presentation was CLI 3-year limb salvage estimates ranging from 69% to slightly more 
than 80%. (77) 
11.6 Axillopopliteal bypass 
Occasionally axillofemoral bypass has been extended to the popliteal artery, primarily for 
cases in which there is groin sepsis and the superficial femoral artery is an unacceptable 
distal target vessel. Patency was inferior to that expected with more conventional 
reconstructions. Nevertheless, this technique is occasionally the only reasonable approach to 
patients with groin sepsis. (78) 
11.7 Obturator bypass 
Obturator bypass used to avoid frankly contaminated fields during reconstruction after the 
removal of infected grafts in the groin, but obturator bypass can also be used for 
reconstruction in patients after the removal of infected ePTFE dialysis access grafts based on 
the femoral arteries; in patients with infected femoral pseudoaneurysms after diagnostic or 
therapeutic femoral arterial access or recreational drug use; in those with groin neoplasms 
requiring en bloc removal of tumor and artery, with a residual soft tissue defect that would 
expose an in situ reconstruction and in patients who have undergone therapeutic radiation 
in the groin. (79, 80)  
11.8 Thoraco-femoral and supraceliac to iliofemoral bypass 
These procedures have most often been applied to patients with failure or infection of 
previous infrarenal aortic reconstructions, previous abdominal surgery for other than aortic 
pathology, prior radiation treatment, or other reasons that would make a conventional 
transperitoneal or retroperitoneal approach to infrarenal aortic surgery difficult or 
impossible and who are not candidates for endovascular intervention. Passman and 
colleagues reported a 5-year primary patency rate of 79% in 50 patients. (81) 
11.9 Laparoscopic aortic surgery 
Laproscopic general surgery shows tremendous advance s, new applications in different 
fields. However, its role in vascular surgery has yet to be defined. Several authors report 
aorto iliac surgical reconstruction performed laparoscopic ally or hand assisted. (82) As the 
technology evolves and intracorporeal anastomotic techniques are refined the rule of 
aortofemoral bypass will expand and become clear.  
11.10 Endovascular treatment 
The advent of endovascular surgery has resulted in a dramatic shift in the treatment of 
patients with aortoiliac occlusive disease. It is likely that even patients with more advanced 
aortoiliac occlusive disease will be candidates for endovascular therapy by means of stent-
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grafts and hybrid open-endovascular approaches. The indication for therapy is similar to the 
indication of open surgery. Patients with disabling claudication constitute the largest group 
of patients who undergo aortoiliac endovascular revascularization. Patients with critical 
limb ischemia (CLI) manifesting as either rest pain or tissue loss frequently have multilevel 
occlusive disease. In patients with a significant CFA disease burden, combined femoral 
artery endarterectomy and patch angioplasty with simultaneous aortoiliac stenting or stent-
grafting often provides adequate perfusion to treat CLI. Juxta renal aortic occlusion, 
circumferential heavy calcification, hypo plastic aortic syndrome, and adjacent aneurysmal 
disease. Renal insufficiency is also a relative contraindication owing to potential contrast-
induced nephropathy, although preventive regimens and minimal contrast techniques have 
reduced the impact of this complication. (1, 83) 
Endovascular therapy is the recommended first-line therapy for TASC A and B lesions and 
increasingly for TASC C lesions as endovascular techniques improve. Good-risk patients with 
TASC type C disease can also be treated with open surgery, depending on patient preference. 
Surgery is usually recommended for TASC D lesions, but advanced endovascular approaches 
are now being applied in these lesions as well, with good results. (1) 
High-risk patients with TASC C and D disease, CLI may be treated with endovascular 
therapy, acknowledging that this approach will be less durable than open surgical options. 
(84) Once a decision has been made that intervention is indicated, information must be 
gathered to determine the location and extent of the atherosclerotic occlusive disease. 
Evaluation of the femoral artery as an access for intervention is crucial. Patients with greater 
than 50% CFA stenosis on duplex arterial mapping, MRA, or CTA are usually treated with a 
hybrid approach that entails open femoral endarterectomy, patch angioplasty, and 
simultaneous stent or stent-graft placement. In patients with less severe CFA disease, a 
percutaneous approach can be under taken and ipsilateral retrograde, contralateral, bilateral 
femoral, or brachial approach can be planned. (85)  
Aortic lesions are frequently calcified, exophytoc and have a higher risk of rupture and 
embolization and stent graft may warranted. 
Different techniques are used for the endovascular treatment of aortoiliac occlusive diseases. 
Common iliac artery (CIA) disease is generally treated through an ipsilateral, retrograde 
approach. A complete diagnostic angiogram can be performed through a catheter in the 
contralateral femoral artery before any intervention; this also provides access to protect the 
contralateral CIA from injury during ipsilateral CIA intervention.  
In general, the contralateral oblique projection shows the iliac artery bifurcations, whereas 
the ipsilateral oblique projection best displays the profunda origins at the femoral artery 
bifurcations. The infrainguinal runoff is visualized before inflow intervention. If the 
obstruction is distal in the external iliac artery it may be better to approach from the 
contralateral because it permits more extensive treatment of the external iliac artery (EIA) 
into the proximal portion of the CFA if needed  
An arterial sheath to facilitate catheter exchanges. The lesion is crossed with a floppy-tipped 
glide wire is used to cross the lesion supported by soft low profile catheter. After advancing 
the catheter across the lesion, the wire is removed, and free aspiration of blood ensures that 
the catheter tip is intraluminal. Injection of contrast follows to confirm the position. Pressure 
measurements across the lesion should be obtained as mentioned in the angiogram 
technique earlier.  
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During the attempt to recanalize an occluded iliac artery in a retrograde fashion, the guide 
wire frequently follows a subintimal path. Once this has occurred, it may be difficult to 
redirect the guide wire into the lumen. Fig 9 (A-G) 
An antegrade approach from the contralateral CFA is frequently successful. As soon as the 
guide wire has crossed the obstructive lesion and lies within the ipsilateral EIA lumen, it is 
snared from the ipsilateral CFA. The hydrophilic guide wire is then removed, and a 
working guide wire is inserted to facilitate the intervention. Fig 10  
If the CIA occlusion is flush with aorta a contralateral femoral approach to cross the lesion is 
generally unsuccessful; transbrachial or ipsilateral femoral approaches are more likely to 
achieve success.  
The recent development of reentry catheters has greatly increased the technical success of 
crossing complete arterial occlusions. 
On angioplasty of the common iliac arteries a ‘Kissing Balloon’ technique which involves 
simultaneous balloon dilatation at the origins of both CIAs is advocated, even in the 
presence of a unilateral lesion, to protect the contralateral CIA from dissection, plaque 
dislodgement, or subsequent embolization. 
If significant CFA disease, a’ hybrid technique’, open femoral approach with combined 
endovascular iliac therapy and femoral endarterectomy should be strongly considered 
Selection of the appropriate balloon or stent diameter is of utmost importance for a 
successful intervention. Slight oversizing of 5% to 10% is recommended, except in the case 
of heavily calcified lesions that may rupture. A calibrated catheter inserted into the vessel 
allows measurement of the artery. The length of the balloon or stent should cover the 
diseased area without damaging the normal vessel. The lesion cause a waist on the balloon 
and the waist disappears after successful dilatation. Mild pain during dilatation is 
acceptable excessive or persistent pain may indicate arterial rupture. Less than 20% residual 
stenosis and less than 10 mm Hg pressure gradient consider a technical success. (86) 
Contrast-induced nephropathy oncidenec can be decreased by preprocedural volume 
loading and the use of low-osmolar or iso-osmolar contrast agents. (87) 
The reported 4-year success rates for iliac angioplasty are approximately 44% to 65%. (88) In 
another study kissing iliac stents showed good results in aortic bifurcation disease with 
primary and secondary patency rates of 78% and 98%, respectively, at 3 years. (89) 
Comparing stenting with stand-alone PTA, he Dutch Iliac Stent Trial Study Group 
performed a randomized comparison of primary balloon-expandable stent placement with 
primary angioplasty followed by selective stent placement in patients with iliac artery 
occlusive disease. Iliac patency ranged from 97% at 3 months to 83% at 5 years in the 
patients with primary stent placement; it ranged from 94% to 74% in the patients treated 
with PTA and selective stent placement. This difference was not significant. (90) 
Other randomized trials have shown primary stenting to be superior to selective stent 
placement The 4-year primary patency rate for claudication, with technical failures 
excluded, was 68% (range, 65% to 74%) after PTA, compared with 77% (range, 72% to 81%) 
after stenting. The 4-year primary patency rate for critical ischemia, with technical failures 
excluded, was 55% (range, 48% to 63%) after PTA, versus 67% (range, 55% to 79%) after 
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stenting. The authors concluded that stent placement reduced the risk of long-term failure 
by 39% compared with PTA alone. (91) 
Meta-analysis of primary iliac artery stent placement in a total of 2058 limbs shows the 
technical success rate was 97%, the complication rate was 6%, and the 5-year primary and 
secondary patency rates were 73% and 85%, respectively.(92) 
Outcomes of iliac intervention depend on TASC lesion classification. Galaria and associates 
examined reported 10-year patency results for patients with TASC types A and B lesions. 
Sixty-two percent of the lesions were TASC type A, and the remainder were type B. Of the 
394 primary interventions, 51% included the placement of stents. Technical success (defined 
as <30% residual stenosis) was achieved in 98% of treated vessels. The procedure-related 
mortality rate was 1.8% at 30 days and 4.7% at 90 days; the procedure-related complication 
rate was 7%. A rise in the ABI >0.15) was achieved in 82%.. Within 3 months, 84% of patients 
demonstrated clinical improvement. The cumulative assisted patency rate was 71% ± 7 at 10 
years. (93) 
Although iliac angioplasty and stenting of TASC types A and B common iliac lesions 
achieve a patency similar to that of open surgical reconstruction, patients with diffuse 
aortoiliac occlusive disease (TASC types C and D lesions) have markedly inferior patency 
with stenting when compared with aortobifemoral bypass. 
Recently, several authors have documented more promising results in the treatment of more 
complex TASC types C and D iliac lesions with 2-year primary patency ranges from 69% to 
76%, with secondary patency rates of 85% to 95%. (94, 95) 
In a series of 212 patients with chronic iliac occlusions, successful recanalization was 
accomplished in nearly 90% of patients, with marked clinical improvement in the vast 
majority. The primary patency at 4 years was 75.7%. (96) 
The primary patency at 4 years was 75.7%. Leville and coworkers recently reported late 
results of the treatment of complex iliac occlusive disease. Three-year primary patency, 
secondary patency, and limb salvage rates were 76%, 90%, and 97%, respectively. (97) 
Extension of disease into the EIA increases procedural complexity and decreases the 
durability of the intervention. (93) 
Rzucidlo and colleagues the use of stent-grafts, (85% TASC types C and D lesions) increased 
the primary and primary assisted patency at 1 year to 70% and 88%, respectively, compared 
with patients treated with stents alone, and led to 100% early hemodynamic and clinical 
success. (98) 
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